PARANEOPLASTIC DERMATOMYOSITIS

PARANEOPLASTIC DERMATOMYOSITIS was reported 93 times

These drug classes are most commonly taken by patients reporting PARANEOPLASTIC DERMATOMYOSITIS:

# Drug Count
0 Platinum-based Drug [EPC] 30
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 25
2 Corticosteroid [EPC] 24
3 Microtubule Inhibitor [EPC] 22
4 Nucleoside Metabolic Inhibitor [EPC] 13
5 Nonsteroidal Anti-inflammatory Drug [EPC] 11
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 10
7 Leukocyte Growth Factor [EPC] 8
8 Androgen Receptor Inhibitor [EPC] 5
9 Estrogen [EPC] 5
10 Factor Xa Inhibitor [EPC] 5
11 Folate Analog Metabolic Inhibitor [EPC] 5
12 Osmotic Laxative [EPC] 5
13 Phenothiazine [EPC] 5
14 Topoisomerase Inhibitor [EPC] 5
15 Tumor Necrosis Factor Blocker [EPC] 5
16 Aromatase Inhibitor [EPC] 3
17 HER2/neu Receptor Antagonist [EPC] 3
18 Human Immunoglobulin G [EPC] 3
19 Thiazide-like Diuretic [EPC] 3
20 Alkylating Drug [EPC] 2
21 Angiotensin Converting Enzyme Inhibitor [EPC] 2
22 Kinase Inhibitor [EPC] 2
23 Platelet Aggregation Inhibitor [EPC] 2
24 Programmed Death Ligand-1 Blocker [EPC] 2
25 Acetylcholine Release Inhibitor [EPC] 1
26 CD20-directed Cytolytic Antibody [EPC] 1
27 CTLA-4-directed Blocking Antibody [EPC] 1
28 Calcium Channel Blocker [EPC] 1
29 Dietary Cholesterol Absorption Inhibitor [EPC] 1
30 Dihydropyridine Calcium Channel Blocker [EPC] 1
31 Epidermal Growth Factor Receptor Antagonist [EPC] 1
32 HMG-CoA Reductase Inhibitor [EPC] 1
33 Loop Diuretic [EPC] 1
34 Neuromuscular Blocker [EPC] 1
35 Phosphodiesterase 5 Inhibitor [EPC] 1
36 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
37 Provitamin D2 Compound [EPC] 1
38 Xanthine Oxidase Inhibitor [EPC] 1